University of Jyvaskyla

Academic/HospitalWebsite ↗

Also known as: PROF, UNIVERSITY OF JYVÄSKYLÄ | University of Jyvaskyla | University of Jyväskylä, Finland | University of Jyväskylä, Replicon Health Oy

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Mar 1, 2015

Last known activity

Mar 31, 2024

Timeline

1930s

Jan 1, 1934
University of Jyvaskyla— Founded

Drugs by trial phase (5 distinct, 3 trials)

Phase 2 (4 own, 0 via acquisition)

aminolevulinic acid
methyl aminolevulinate
estradiol
hexyl 5-aminolevulinate

Phase 1 (1 own, 0 via acquisition)

calcium chloride

Indications

Studied for

Basal Cell Carcinoma
Neoplasms, Basal Cell

Recent trials (5)

NCT06271551CollaboratorPhase 2Mar 31, 2024
NCT04713319Study directorEarly Phase 1Oct 4, 2019
NCT04713319CollaboratorEarly Phase 1Oct 4, 2019
NCT04713319Overall official - principal investigatorEarly Phase 1Oct 4, 2019
NCT02367547CollaboratorPhase 1/Phase 2Mar 1, 2015

Details

Founded: Jyväskylä, FI Jan 1, 1934
Last known activity: Mar 31, 2024